(Total Views: 399)
Posted On: 08/22/2019 5:59:41 AM
Post# of 154853
New interview with Nader
On the Stock Day podcast:
https://audioboom.com/posts/7348426-cytodyn-j...iv-program
I heard some very encouraging things and one thing that concerns me.
First, the concerning is that the first Samsung payment will be due in March, which seems early to me. That date does sound like it's contingent on approval date though.
The good is that Nader sounds very confident about:
Two deals on the table to launch leronlimab with a both significant amount of money upfront and milestone payments
Also says they are very close to signing a licensing term sheet.and getting final agreement.
On the Stock Day podcast:
https://audioboom.com/posts/7348426-cytodyn-j...iv-program
I heard some very encouraging things and one thing that concerns me.
First, the concerning is that the first Samsung payment will be due in March, which seems early to me. That date does sound like it's contingent on approval date though.
The good is that Nader sounds very confident about:
Two deals on the table to launch leronlimab with a both significant amount of money upfront and milestone payments
Also says they are very close to signing a licensing term sheet.and getting final agreement.
(4)
(0)
